Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05041660 · ClinicalTrials.gov registry record · NA
Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating
A NA study, sponsored by Drexel University.
- Completed
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT05041660: Completed NA study, sponsored by Drexel University.
NCT05041660 is a NA study that has completed, run by Drexel University. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05041660, a NA study, has completed, sponsored by Drexel University.
- COMPLETED
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
This study evaluates whether virtual-reality-based inhibitory control trainings are more effective than computerized trainings in reducing binge eating symptomatology. These trainings are used to improve people's ability to resist their impulses towards highly palatable foods (such as chips or cookies). These trainings also offer promise as a companion to Cognitive Behavioral Therapy, an often used and relatively effective therapeutic methodology.
Primary Outcome
This outcome will be assessed according to whether the investigators can recruit at least 40 participants. This forms the first half of the assessment of the protocol's feasibility.
Interventions
- OTHER Virtual-reality-based training
- OTHER Inhibitory Control Training
- OTHER Sham Inhibitory Control Training
- OTHER Computerized training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2020-08-05 |
| Phase | NA |
What the finished NCT05041660 record still lists
NCT05041660 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Virtual-reality-based training is the first listed.
NCT05041660 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05041660 about?
NCT05041660 is a clinical study titled "Using Virtual Reality and Sensor Technology to Enhance Outcomes From Treatment for Binge Eating". This study evaluates whether virtual-reality-based inhibitory control trainings are more effective than computerized trainings in reducing binge eating symptomatology. These trainings are used to improve people's ability to resist their impulses towards highly palatable foods (such as chips or cooki...
What is the current status of trial NCT05041660?
This trial is currently completed. It is a NA study. The enrollment target is 41 participants. The study started on 2019-10-14. Estimated completion is 2020-08-05.
What interventions are being tested in trial NCT05041660?
The interventions under investigation include: Virtual-reality-based training (OTHER), Inhibitory Control Training (OTHER), Sham Inhibitory Control Training (OTHER), Computerized training (OTHER).
Who is sponsoring clinical trial NCT05041660?
This trial is sponsored by Drexel University, which has 92 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05041660's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI